Literature DB >> 10075261

Individualized phantom based on CT slices and auxological data (ICTA) for dose estimations following radiotherapy for skin haemangioma in childhood.

L Ligot1, I Diallo, A Shamsaldin, J Chavaudra, C BonaIti-Pellié, F de Vathaire.   

Abstract

BACKGROUND AND
PURPOSE: Before 1974 about 5000 children were treated by radiotherapy at the Institut Gustave-Roussy (IGR) for a skin haemangioma. A human model whose characteristics are as close as possible to those of the patient at the time of the treatment is necessary to effectuate an accurate retrospective estimation of the radiation doses received at distant organs.
METHODS: We have developed a software package which constructs an individualized phantom based on CT slices and auxological data (ICTA) for this purpose. A set of real CT slices is used to produce a 3-D representation of the human body which is then adjusted to fit the dimensions supplied by published auxological data relative to sex and age for each patient. One hundred sixty-one anatomical landmarks of epidemiological interest have been defined inside the phantom for dose estimation.
RESULTS: The transverse, frontal and sagittal views of the phantom displayed permit accurate positioning of radioactive applicators. The software calculates the relevant parameters required for dose estimation based on the patient's probable anatomy.

Entities:  

Mesh:

Year:  1998        PMID: 10075261     DOI: 10.1016/s0167-8140(98)00099-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Reconstruction of organ dose for external radiotherapy patients in retrospective epidemiologic studies.

Authors:  Choonik Lee; Jae Won Jung; Christopher Pelletier; Anil Pyakuryal; Stephanie Lamart; Jong Oh Kim; Choonsik Lee
Journal:  Phys Med Biol       Date:  2015-02-26       Impact factor: 3.609

2.  Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.

Authors:  M P Little; M L Schaeffer; R C Reulen; D H Abramson; M Stovall; R Weathers; F de Vathaire; I Diallo; J M Seddon; M M Hawkins; M A Tucker; R A Kleinerman
Journal:  Br J Cancer       Date:  2014-04-22       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.